The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir

BACKGROUND: There are limited options for chronic hepatitis B (CHB) patients who have poor responses to adefovir (ADV). OBJECTIVES: The aim of this study is to evaluate the effects of adding on telbivudine (LdT) or switching to pegylated interferon alfa-2a (PEG-IFN-α2a) as alternative rescue therapi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepat Mon
Egile Nagusiak: Wei, Xin, Fan, Chao, Zhou, Yun, Kang, Wenzhen, Wang, Jiuping, Sun, Li, Wang, Linxu, Peng, Meijuan, Lian, Jianqi, Jia, Zhansheng, Hao, Chunqiu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Kowsar 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834190/
https://ncbi.nlm.nih.gov/pubmed/27110255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.31278
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak